Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Metabolic Syndrome: A Ticking Time Bomb

01.12.2004


EU research to tackle the problem



Both obesity and type 2 diabetes have become global epidemics over recent decades bringing, in their wake, a number of metabolic symptoms and cardiovascular disease risk factors. Both of these disorders, however, are just the tip of the iceberg, being just two manifestations of the metabolic syndrome (see notes to editors) which has been suggested to affect 25% of the adult population in countries such as the UK, and has severe consequences for both public health and the economy. Research is being conducted across Europe to help tackle the metabolic syndrome and its
associated complications.

Between 10-20% of men and 10-25% of women in Europe are obese and by the year 2010, it is estimated that as many as 31 million people across Europe will need treatment for diabetes and related complications. Many of these people will display symptoms of the metabolic syndrome.



The rising prevalence of the metabolic syndrome needs to be tackled with urgency in order to prevent a public health catastrophe and huge costs to the health service and economy across Europe. Tackling the metabolic syndrome will require a huge and integrated societal effort.

Research is under way across Europe to establish the role of diet in the development of the metabolic syndrome and ways in which its prevalence and associated complications can be reduced, through the foods and diet that we eat. This research is being conducted by a pan European consortium of 24 research partners and is known as the Lipgene project (see notes to editors).

Our diets influence risk of developing chronic disease by interacting with the genes we have inherited (our genotype). For this reason, the genetic susceptibility for the metabolic syndrome is being determined, along with the role that diet, especially dietary fat, plays in the aetiology of the condition.

It is believed that changing the fatty acid composition of the diet, by replacing foods high in saturated fat (associated with an increased risk of heart disease) with foods high in unsaturated fat and increasing intakes of long-chain omega-3 fatty acids (i.e. DHA and EPA present in large amounts in oily fish) is a crucial step to help achieve a reduction in the prevalence and burden of the metabolic syndrome. But fish stocks are limited and not everyone likes oily fish. For example, in the UK around 60% of people typically don’t eat it and average weekly intake is about a third of a serving per person. Therefore, an alternative and sustainable source of long chain omega-3 fatty acids is needed to ensure optimal dietary intakes are achieved.

Innovative and cutting edge technology is being used in Lipgene to develop foods with modified fat compositions; for example, milks with a more unsaturated fatty acid profile and plant oils containing long chain omega-3 fatty acids. Such foods have the potential to play an invaluable role, in the future, in the battle against the rising tide of the metabolic syndrome, type 2 diabetes and cardiovascular disease, without consumers having to make major changes to their dietary habits. However, for novel foods to have an impact they must first be accepted by consumers. Acceptability of such food products will be explored. The cost implications of their production will be compared with the total costs to the EU economy of treating the metabolic syndrome and its complications.

A one-day conference is being held in London, on December 1st, to discuss the consequences of the metabolic syndrome, the Lipgene project and ways in which the metabolic syndrome can be tackled in terms of the food we eat.

Duty Editor | alfa
Further information:
http://www.nutrition.org.uk

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>